TY  - JOUR

T1  - Cost effectiveness of long-acting risperidone in Sweden.

JO  - Appl Health Econ Health Policy

PY  - 2010/01/01

AU  - Hensen M

AU  - Heeg B

AU  - Löthgren M

AU  - van Hout B

ED  - 

DO  - DOI: 10.2165/11536180-000000000-00000

VL  - 8

IS  - 5

SP  - 327

EP  - 341

Y2  - 2024/12/22

ER  -